1. Home
  2. FFBC vs RARE Comparison

FFBC vs RARE Comparison

Compare FFBC & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

HOLD

Current Price

$30.19

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$23.56

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFBC
RARE
Founded
1863
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FFBC
RARE
Price
$30.19
$23.56
Analyst Decision
Buy
Strong Buy
Analyst Count
7
19
Target Price
$29.50
$73.11
AVG Volume (30 Days)
1.3M
2.2M
Earning Date
01-28-2026
02-12-2026
Dividend Yield
3.28%
N/A
EPS Growth
10.83
N/A
EPS
2.66
N/A
Revenue
$861,817,000.00
$630,598,000.00
Revenue This Year
$26.94
$20.38
Revenue Next Year
$4.48
$19.02
P/E Ratio
$11.45
N/A
Revenue Growth
13.99
20.63
52 Week Low
$21.10
$18.41
52 Week High
$31.38
$46.27

Technical Indicators

Market Signals
Indicator
FFBC
RARE
Relative Strength Index (RSI) 67.65 41.78
Support Level $29.26 $23.76
Resistance Level $31.38 $24.68
Average True Range (ATR) 0.97 1.06
MACD 0.15 0.23
Stochastic Oscillator 75.77 23.36

Price Performance

Historical Comparison
FFBC
RARE

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: